Common Stock, Shares, Issued of Taysha Gene Therapies, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Taysha Gene Therapies, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Taysha Gene Therapies, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 273,915,373, a 34% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Taysha Gene Therapies, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 273,915,373 +68,972,067 +34% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 272,730,060 +71,348,610 +35% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 205,054,570 +18,036,295 +9.6% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 204,943,306 +17,983,113 +9.6% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 204,943,306 +17,983,113 +9.6% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 201,381,450 +136,948,813 +213% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 187,018,275 +123,544,926 +195% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 186,960,193 +123,752,686 +196% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 186,960,193 +145,784,254 +354% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 64,432,637 +23,412,551 +57% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 63,473,349 +24,999,404 +65% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 63,207,507 +24,733,562 +64% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 41,175,939 +2,701,994 +7% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 41,020,086 +2,628,921 +6.8% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 38,473,945 +712,510 +1.9% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 38,473,945 +712,510 +1.9% 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 38,473,945 +712,510 +1.9% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 38,391,165 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 37,761,435 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 37,761,435 +26,866,436 +247% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 37,761,435 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q4 2019 10,894,999 31 Dec 2019 10-K 03 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.